The B2B Manufacturing Industry Directory
The 100% Section 232 duty on patented pharmaceuticals began July 31, 2026, with a second cohort starting September 29. What API suppliers face.
Read more →
The first-ever Section 338 action put a 50% duty on about $20 billion of Canadian goods. A three-day pause expired without a deal and the duty took effect …
Read more →
Tariff policy promised a wave of US reshoring. Trade data instead shows a lot of production relocating to other Asian and nearshore markets rather than coming …
Read more →
Tariffs get the headlines, but the real ceiling on US reshoring is workforce availability. A buyer's framework for vetting a domestic supplier's labor stability …
Read more →
The June 8, 2026 Section 232 proclamation restructured steel, aluminum, and copper tariffs into a tiered 0–50% framework applied to full customs value. A …
Read more →
A procurement-side look at whether tariffs are actually rebuilding US manufacturing—BLS job data, facility announcements, and the gap between rhetoric and …
Read more →The first-ever Section 338 action put a 50% duty on about $20 billion of Canadian goods. A three-day pause expired without a deal and the duty took effect …
Read more →The 100% Section 232 duty on patented pharmaceuticals began July 31, 2026, with a second cohort starting September 29. What API suppliers face.
Read more →Tariff policy promised a wave of US reshoring. Trade data instead shows a lot of production relocating to other Asian and nearshore markets rather than coming …
Read more →